Emergent BioSolutions is a life sciences company focused on providing preparedness and response solutions that address accidental, deliberate and naturally occurring public health threats (PHTs). The types of PHTs Co. is addressing are focused on the following five categories: chemical, biological, radiological, nuclear and explosives; emerging infectious diseases; travel health; public health crises (such as the opioid crisis and the COVID-19 pandemic); and acute, emergency, and community care. Co. operates under three separate business lines: the Government - Medical Countermeasures; the Commercial; and the Services - contract development and manufacturing. The EBS stock yearly return is shown above.
The yearly return on the EBS stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the EBS annual return calculation with any dividends reinvested as applicable (on ex-dates).
|